Table 4.

Summary measures of the difference in rating of degree of malignancy of tissue from pretreatment to six months on study, by study arm

Study armNMean (SD)MedianSmallestLargest
Drug411.2 (23.7)0−8671
Placebo473.6 (15.4)0−2059
TOTAL882.5 (19.6)0−8671

NOTE: Negative scores indicate a change toward normal tissue. Positive scores indicate a change toward malignancy. Values of zero indicate no change.